Logo image of IMMR

IMMERSION CORPORATION (IMMR) Stock Fundamental Analysis

NASDAQ:IMMR - Nasdaq - US4525211078 - Common Stock - Currency: USD

7.49  -0.01 (-0.13%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IMMR. IMMR was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. While IMMR is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on IMMR.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IMMR had positive earnings in the past year.
Of the past 5 years IMMR 4 years were profitable.
IMMR had a positive operating cash flow in 4 of the past 5 years.
IMMR Yearly Net Income VS EBIT VS OCF VS FCFIMMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

IMMR has a Return On Assets of 2.86%. This is in the better half of the industry: IMMR outperforms 65.63% of its industry peers.
IMMR has a better Return On Equity (14.75%) than 84.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.89%, IMMR is in line with its industry, outperforming 46.88% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IMMR is significantly below the industry average of 16.87%.
The last Return On Invested Capital (1.89%) for IMMR is well below the 3 year average (9.10%), which needs to be investigated, but indicates that IMMR had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROIC 1.89%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
IMMR Yearly ROA, ROE, ROICIMMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

IMMR's Profit Margin of 100.17% is amongst the best of the industry. IMMR outperforms 100.00% of its industry peers.
IMMR's Profit Margin has improved in the last couple of years.
IMMR's Operating Margin of 52.85% is amongst the best of the industry. IMMR outperforms 100.00% of its industry peers.
IMMR's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 52.85%
PM (TTM) 100.17%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
IMMR Yearly Profit, Operating, Gross MarginsIMMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

2

2. Health

2.1 Basic Checks

IMMR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IMMR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, IMMR has more shares outstanding
There is no outstanding debt for IMMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMMR Yearly Shares OutstandingIMMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
IMMR Yearly Total Debt VS Total AssetsIMMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

IMMR has an Altman-Z score of 0.49. This is a bad value and indicates that IMMR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.49, IMMR is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
IMMR has a Debt/Equity ratio of 0.81. This is a neutral value indicating IMMR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.81, IMMR is in line with its industry, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 0.49
ROIC/WACC0.21
WACC9.1%
IMMR Yearly LT Debt VS Equity VS FCFIMMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.55 indicates that IMMR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.55, IMMR is in line with its industry, outperforming 53.13% of the companies in the same industry.
IMMR has a Quick Ratio of 1.55. This is a bad value and indicates that IMMR is not financially healthy enough and could expect problems in meeting its short term obligations.
IMMR has a Quick ratio of 0.72. This is in the lower half of the industry: IMMR underperforms 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.72
IMMR Yearly Current Assets VS Current LiabilitesIMMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.12% over the past year.
The Earnings Per Share has been decreasing by -9.60% on average over the past years.
IMMR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.81%.
Measured over the past years, IMMR shows a very negative growth in Revenue. The Revenue has been decreasing by -21.11% on average per year.
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%

3.2 Future

IMMR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.87% yearly.
IMMR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 189.84% yearly.
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMMR Yearly Revenue VS EstimatesIMMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
IMMR Yearly EPS VS EstimatesIMMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.99, the valuation of IMMR can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.60. IMMR is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 2.28 indicates a rather cheap valuation of IMMR.
96.88% of the companies in the same industry are more expensive than IMMR, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.43, IMMR is valued rather cheaply.
Industry RankSector Rank
PE 5.99
Fwd PE 2.28
IMMR Price Earnings VS Forward Price EarningsIMMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

65.63% of the companies in the same industry are more expensive than IMMR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.04
IMMR Per share dataIMMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMMR may justify a higher PE ratio.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%

3

5. Dividend

5.1 Amount

IMMR has a Yearly Dividend Yield of 2.34%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.74, IMMR pays a better dividend. On top of this IMMR pays more dividend than 87.50% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, IMMR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.34%

5.2 History

IMMR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IMMR Yearly Dividends per shareIMMR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%
IMMR Yearly Income VS Free CF VS DividendIMMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

IMMERSION CORPORATION

NASDAQ:IMMR (5/21/2025, 1:15:50 PM)

7.49

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)03-12 2025-03-12/bmo
Earnings (Next)08-18 2025-08-18
Inst Owners59.01%
Inst Owner Change-1.39%
Ins Owners5.04%
Ins Owner Change-1.32%
Market Cap242.68M
Analysts82.5
Price Target12.5 (66.89%)
Short Float %9.37%
Short Ratio6.79
Dividend
Industry RankSector Rank
Dividend Yield 2.34%
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date04-14 2025-04-14 (0.045)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.99
Fwd PE 2.28
P/S 7.15
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 2
EV/EBITDA 11.04
EPS(TTM)1.25
EY16.69%
EPS(NY)3.28
Fwd EY43.85%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.05
BVpS7.11
TBVpS3.74
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROCE 2.39%
ROIC 1.89%
ROICexc 2.3%
ROICexgc 2.8%
OM 52.85%
PM (TTM) 100.17%
GM N/A
FCFM N/A
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
ROICexc(3y)48.9%
ROICexc(5y)N/A
ROICexgc(3y)48.9%
ROICexgc(5y)N/A
ROCE(3y)11.5%
ROCE(5y)N/A
ROICexcg growth 3Y84.52%
ROICexcg growth 5YN/A
ROICexc growth 3Y84.52%
ROICexc growth 5Y-44.16%
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA 10.37
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.72
Altman-Z 0.49
F-ScoreN/A
WACC9.1%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)109.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A
EBIT growth 1Y-26.59%
EBIT growth 3Y101.23%
EBIT growth 5Y-19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.65%
FCF growth 3YN/A
FCF growth 5Y-21.67%
OCF growth 1Y-48.69%
OCF growth 3Y909.9%
OCF growth 5Y-21.68%